# Optimal Prophylactic Method of Venous Thromboembolism (VTE)

> **NCT01448746** · PHASE3 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 682 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** low molecular weight heparin

## Key facts

- **NCT ID:** NCT01448746
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2016-01
- **Final completion:** 2017-08
- **Target enrollment:** 682 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448746, "Optimal Prophylactic Method of Venous Thromboembolism (VTE)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01448746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*